Available studies indicate that the adrenergic stimulation of pineal c
yclic GMP production involves stimulation of guanylyl cyclase activity
by nitric oxide (NO) derived from arginine. This line of investigatio
n was extended in the present study. Using a highly sensitive microass
ay, it was found that pineal NO synthase activity is present at levels
similar to 30% of those in the cerebellum, that approximately 95% of
enzyme activity is cytoplasmic, that the enzyme is Ca2+/calmodulin-dep
endent and that enzyme activity is inhibited by the arginine analog N-
G-nitro-L-arginine methyl ester (L-NAME). Norepinephrine treatment of
intact glands in culture increased [H-3]citrulline formation from [H-3
]arginine. This treatment also increased the formation of an NO-like c
ompound, indicating that NO synthase activity in the intact gland is e
levated by adrenergic stimulation. Studies on the effects of inhibitio
n of NO synthase activity indicated that treatments known to inhibit N
O synthase activity and the adrenergic stimulation of cyclic GMP accum
ulation did not inhibit adrenergic stimulation of pineal cyclic AMP, N
-acetyltransferase activity or melatonin production. These observation
s support the hypothesis that NE stimulation of pineal cyclic GMP accu
mulation involves stimulation of a Ca2+/calmodulin-sensitive form of N
O synthase, resulting in enhanced accumulation of NO; and, that althou
gh NO appears to play a role in the adrenergic stimulation of pineal c
yclic GMP accumulation, it does not appear to play a critical role in
the adrenergic stimulation of cyclic AMP, N-acetyltransferase activity
or melatonin production.